Medical Excellence Capital is a venture capital company that invests in early-stage breakthrough life science companies. Our investment thesis centers on advancing healthcare through disruptive innovation in gene/cell therapy, regenerative medicine, synthetic biology, AI in drug discovery, and precision medicine.